Literature DB >> 19591437

Evidence for trisulfide bonds in a recombinant variant of a human IgG2 monoclonal antibody.

Pavlo Pristatsky1, Steven L Cohen, Debra Krantz, Jillian Acevedo, Roxana Ionescu, Josef Vlasak.   

Abstract

The hinge region of human IgG2 contains four cysteine residues involved in disulfide linkages between the heavy chains, as well as the heavy and light chains. These linkages provide the fundamental framework of three distinct IgG2 disulfide isoforms recently described. Here, we detail another, disulfide-related post-translational modification in a recombinant variant of human IgG2. Heterogeneity associated with this antibody was separated into several fractions by anion-exchange chromatography (AEX), which is an important initial step that highlights the resolving power of surface charge-based HPLC techniques. Mass spectrometry of the intact antibody revealed weakly resolved discrete covalent additions of 25-35 Da in one of the two main AEX fractions. Digestion by endoproteinase Lys-C performed under nonreducing conditions, as well as tandem MS experiments, narrowed the modification to the peptide-containing disulfide-bridged hinge structure. High mass resolution and accuracy measurements of the peptide strongly suggested an addition of one or two S atoms. The modification could be eliminated by a mild reducing treatment of the intact antibody. Overall, these findings are consistent with the replacement of up to two disulfide bridges (S-S) with a like number of trisulfides (S-S-S) in the antibody hinge. The trisulfide modification is rather uncommon for proteins and its possible origins in the IgG2 variant are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591437     DOI: 10.1021/ac9006254

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  20 in total

1.  An innovative approach for the characterization of the isoforms of a monoclonal antibody product.

Authors:  Shanmuuga Sundaram; Alice Matathia; Jun Qian; Jingming Zhang; Ming-Ching Hsieh; Tun Liu; Richard Crowley; Babita Parekh; Qinwei Zhou
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

Review 2.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

Review 3.  Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies.

Authors:  Yi Du; Alison Walsh; Robin Ehrick; Wei Xu; Kimberly May; Hongcheng Liu
Journal:  MAbs       Date:  2012-07-23       Impact factor: 5.857

Review 4.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Guanbo Wang; Burcu Baykal; Shunhai Wang
Journal:  Biotechnol Adv       Date:  2011-05-17       Impact factor: 14.227

Review 5.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

6.  The impact of trisulfide modification of antibodies on the properties of antibody-drug conjugates manufactured using thiol chemistry.

Authors:  Renpeng Liu; Xuan Chen; Junia Dushime; Megan Bogalhas; Alexandru C Lazar; Thomas Ryll; Lintao Wang
Journal:  MAbs       Date:  2017-01-31       Impact factor: 5.857

7.  IgG1 thioether bond formation in vivo.

Authors:  Qingchun Zhang; Matthew R Schenauer; John D McCarter; Gregory C Flynn
Journal:  J Biol Chem       Date:  2013-04-25       Impact factor: 5.157

8.  Impact of S-sulfocysteine on fragments and trisulfide bond linkages in monoclonal antibodies.

Authors:  Ronja Seibel; Sandra Maier; Alisa Schnellbaecher; Susanne Bohl; Maria Wehsling; Anne Zeck; Aline Zimmer
Journal:  MAbs       Date:  2017-06-05       Impact factor: 5.857

Review 9.  In vitro and in vivo modifications of recombinant and human IgG antibodies.

Authors:  Hongcheng Liu; Gomathinayagam Ponniah; Hui-Min Zhang; Christine Nowak; Alyssa Neill; Nidia Gonzalez-Lopez; Rekha Patel; Guilong Cheng; Adriana Z Kita; Bruce Andrien
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

10.  Desulfurization of cysteine-containing peptides resulting from sample preparation for protein characterization by mass spectrometry.

Authors:  Zhouxi Wang; Tomas Rejtar; Zhaohui Sunny Zhou; Barry L Karger
Journal:  Rapid Commun Mass Spectrom       Date:  2010-02       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.